The 2007 WHO classification of tumours of the central nervous system

DN Louis, H Ohgaki, OD Wiestler, WK Cavenee… - Acta …, 2007 - Springer
The fourth edition of the World Health Organization (WHO) classification of tumours of the
central nervous system, published in 2007, lists several new entities, including angiocentric …

Malignant gliomas in adults

PY Wen, S Kesari - New England Journal of Medicine, 2008 - Mass Medical Soc
Malignant gliomas, the most common type of primary brain tumor in adults, are associated
with disproportionate cancer-related morbidity and mortality. Recently, there have been …

Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology

LB Nabors, J Portnow, M Ahluwalia, J Baehring… - Journal of the National …, 2020 - jnccn.org
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of
adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas …

Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline

NA Mohile, H Messersmith, NTN Gatson, AF Hottinger… - 2022 - academic.oup.com
Purpose To provide guidance to clinicians regarding therapy for diffuse astrocytic and
oligodendroglial tumors in adults. Methods ASCO and the Society for Neuro-Oncology …

EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma

M Weller, M Van Den Bent, K Hopkins, JC Tonn… - The lancet …, 2014 - thelancet.com
This guideline provides recommendations for diagnostic and therapeutic procedures for
patients with malignant gliomas. We differentiate evidence-based standards from …

[HTML][HTML] CGCG clinical practice guidelines for the management of adult diffuse gliomas

T Jiang, Y Mao, W Ma, Q Mao, Y You, X Yang, C Jiang… - Cancer letters, 2016 - Elsevier
Abstract The Chinese Glioma Cooperative Group (CGCG) Guideline Panel for adult diffuse
gliomas provided recommendations for diagnostic and therapeutic procedures. The Panel …

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402

G Cairncross, M Wang, E Shaw, R Jenkins… - Journal of clinical …, 2013 - ascopubs.org
Purpose Anaplastic oligodendrogliomas, pure (AO) and mixed (anaplastic oligoastrocytoma
[AOA]), are chemosensitive, especially if codeleted for 1p/19q, but whether patients live …

Primary brain tumours in adults

D Ricard, A Idbaih, F Ducray, M Lahutte… - The Lancet, 2012 - thelancet.com
Important advances have been made in the understanding and management of adult
gliomas and primary CNS lymphomas—the two most common primary brain tumours …

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

A Olar, KM Wani, KD Alfaro-Munoz, LE Heathcock… - Acta …, 2015 - Springer
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

M Weller, R Stupp, G Reifenberger… - Nature Reviews …, 2010 - nature.com
The DNA repair enzyme O 6-methylguanine-DNA methyltransferase (MGMT) antagonizes
the genotoxic effects of alkylating agents. MGMT promoter methylation is the key mechanism …